Buying weed Switzerland

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buying weed Switzerland

Cannabis has always had an important place in the cultures of the world, with an image as virtuous as it is disparaged. Indeed, despite the psychotropic effect of its main molecule THC, many people recognize the medicinal benefits of cannabis. However, today, the vast majority of countries continue to prohibit it. It is one of the narcotic products as categorized by the United Nations Single Convention. This convention strongly limits the possibilities of production and trade of narcotics. Switzerland, on the other hand, has strictly prohibited cannabis in its law since According to this law, it is forbidden to cultivate, produce or sell cannabis on Swiss territory. In , this law was extended to punish even the consumption. But things have been moving in the opposite direction since the year Nowadays, legal Swiss cannabis can be found on every street corner. In Switzerland, you can find cannabidiol products at Coop or Denner. Today, even some gas stations or kiosks offer Swiss cannabis products. However, it is in specialized CBD stores online or not such as uWeed that you will find legal cannabis in Switzerland of very high quality. According to the Tages-Anzeiger, this growth will continue. The law on narcotics LStup and its ordinances contain the provisions for the management of narcotics and psychotropic substances. It also deals with the distribution of tasks between the national and cantonal authorities. This is what is more commonly known as cannabis, whether it is recreational or medicinal. It is sold on the black and illegal market. These products with a limited THC content are legal in Switzerland although their marketing is regulated. Obviously, when we talk about cannabis, the words decriminalization, legalization, decriminalization, are usually associated. To understand the issues surrounding cannabis, here are the differences to remember between these different terms. Decriminalizing the possession and use of cannabis means that it is no longer considered a crime. The act remains prohibited, but the sanctions are only administrative, such as a fine. This is the case in Switzerland for the consumption of a small amount of cannabis, i. A person in Switzerland can therefore possess up to 10 grams of cannabis and only be fined in case of control. Legalization means the removal of a ban. In the case of legalization of cannabis as in the Netherlands , the consumption, production and sale of cannabis are no longer sanctioned, neither criminally nor administratively. Legalization does not mean absolute liberalization or free access. Be careful though, even if a substance becomes legal, its possession and trade can still be regulated. Regulation refers to the creation and enforcement of rules to govern the use, possession and trade of cannabis. This may include setting a minimum age for consumption or setting rules for controlling production or sale. Penal or administrative sanctions may be imposed for any breach of these rules, as in other sectors such as food, for example. While the second half of the 20th century was rather unfavourable to the legalization of recreational cannabis, it seems that Switzerland has been in a more progressive position since the early s. However, there has been considerable progress in recent years, which we summarize below. Consumption and possession of less than 10 grams of cannabis is now considered a simple offence and punishable by a fine of CHF for adult consumers art. Minors remain subject to the criminal law for minors. According to the Swiss Addiction Monitoring, approximately 7. Cannabis is the most frequently used drug in Switzerland. About one third of the population aged 15 and over have already experimented with this drug. It appears that repression has never been effective in curbing cannabis use, let alone in eliminating the black market. As a result, Swiss lawmakers concluded that other regulatory options needed to be explored. At its March 31, meeting, the Federal Council passed the Cannabis Pilot Trials Ordinance , which sets a detailed framework for the dispensing of cannabis products for non-medical use. Prescription medical use is not included in these trials, which we will discuss at greater length later in this article. On May 15, , an amendment to the LStup went into effect, allowing pilot testing for the controlled sale of cannabis for recreational purposes. This amendment will remain in effect for ten years, and serves as the legal basis for the implementation of scientific cannabis pilot tests. The pilot tests will allow consumers to legally purchase a wide range of cannabis products. The latter will have to meet high quality standards, with strict transparency from seed to sale, and must be organically grown which by definition excludes indoor flower cultivation. The objective of these studies is to broaden the knowledge about the advantages and disadvantages of controlled access to cannabis. They should facilitate the examination and documentation of the health consequences and consumption patterns of users in a scientific setting. These studies will also provide data on the effects on the local illicit drug market, as well as on the protection of minors and children. To host these pilot tests, a number of Swiss cities have been selected such as Basel the first city to be accepted , Bern, Geneva, Zurich and Lausanne. In the fall of , Zurich, the largest city in Switzerland, will allow the sale of recreational cannabis in pharmacies but also in Social Clubs. Addiction Suisse is the partner chosen by the city to lead the scientific part. The supervision of the sale of cannabis is entrusted to a non-profit association. It bears the same name as the trial: Cann-L. On the sidelines of the pilot projects, on September 25, , Heinz Siegenthaler, member of the Swiss National Council, filed a new parliamentary initiative. The reasoning accompanying the original text of the initiative describes an inconsistency of cannabis prohibition based on current scientific research, especially when compared to other harmful substances such as tobacco and alcohol. The Federal Council simply considered that the LStup has not fulfilled its objective of protecting the population, given the more than , regular cannabis users in Switzerland. This justifies the replacement of the current prohibition by a fully regulated cannabis market, meeting the requirements of Swiss addiction and health policy. On April 28, , the Health Committee of the Swiss National Council voted in favor of controlled legalization of cannabis. This is the first major political hurdle of the parliamentary initiative. This latest political development around cannabis legislation is proof of the urgency to regulate this growing market for the general public. The limited view of cannabis as an allegedly harmful drug and the stigmatization of its users are giving way to recognition of its significant medical potential , as well as the promising economic growth it could generate through recreational and industrial use. With its already progressive regulatory framework regarding THC thresholds compared to the rest of Europe and a liberalization of cannabis for medical purposes, Switzerland is in an excellent position to strengthen its leadership position in Europe. In Switzerland, the slow administrative process as well as expensive procedures to obtain medical cannabis have pushed patients to the black market. This health problem has led to an amendment of the cannabis law on March 19, The regulations on the use of medical products and medical devices are set out in the following laws:. These laws and regulations apply to therapeutic products, which include medical cannabis products. Ready-to-use medical products can only be placed on the market if they are authorized by Swissmedic. The application for a marketing authorization for medical cannabis products must include, for example, detailed documentation of the results of physical, chemical and biological or microbiological tests, as well as the results of pharmacological and toxicological tests and clinical trials. The applicant must prove that the medical products are of high quality, safe and effective. It can be prescribed without special authorization for spastic convulsions in patients with multiple sclerosis. The manufacture of medical products and pharmaceutical derivatives e. The GMP guidelines provide the minimum requirements that a manufacturer of medical products must meet to ensure that their products are of consistently high enough quality for their intended use. Medical cannabis not to be confused with recreational cannabis is therefore also becoming increasingly popular for its benefits. Measures have been taken to allow its commercialization, and therefore its purchase by individuals, either in the form of medicine or in the form of cannabis flowers weed. In order to obtain medical cannabis, you must first obtain a prescription from your doctor , who will support your request to the Federal Office of Public Health OFSP. Please note that special permits can only be issued by doctors practicing in Switzerland and for patients residing in Switzerland. Beware, even as a medical treatment with a special permit, cannabis contains THC: it is therefore not possible to drive after its consumption, nor to travel with it in other countries where the legislation is not as flexible. As seen previously, there are multiple constraints to selling cannabis. There are just as many for its production. Such authorizations are only issued for purposes related to a limited medical application, scientific research or the development of medicines. Concerning medical cannabis products, the rules are not the same, as they are dictated by SwissMedic directly. Only this organization can validate a medical cannabis product. Once the application has been studied, the Federal Office of Public Health will decide if the project is feasible. To become a producer of recreational cannabis within the framework of the pilot tests , it is necessary :. In order to make the quality of the plants and their THC concentration homogeneous it is necessary to produce indoors. In outside, many external elements can influence the parameters of the plants. Home production of cannabis for personal consumption remains prohibited, as it cannot meet the requirements set by the FOPH for the cultivation of recreational cannabis. The cultivation of cannabis therefore remains exclusive to professionals licensed by the Swiss state. Swiss citizens cannot grow their own cannabis at home for the moment, even in small doses. However, this allows everyone to buy only from highly specialized and controlled outlets, and to benefit only from very high quality products. It is also generally called legal cannabis or Swiss legal cannabis, as the CBD molecule does not cause a high. The effects of CBD are widely acclaimed, both by consumers and the medical profession. The consumption of legal cannabis has been increasing rapidly in the last few years, leading to the opening of numerous online CBD stores. Although CBD is a legal substance, there are still many regulations and restrictions on how companies can market it. In addition, research is advancing strongly every year to further demonstrate the benefits of Swiss legal cannabis. Cannabis regulations in Table of contents on cannabis in Switzerland Understanding the terms of the cannabis legislation Switzerland moves towards legalization of recreational cannabis What does the Swiss law say about medical cannabis? Decriminalization or Depenalization Decriminalizing the possession and use of cannabis means that it is no longer considered a crime. Cannabis legalization Legalization means the removal of a ban. Regulation or regulation of cannabis Regulation refers to the creation and enforcement of rules to govern the use, possession and trade of cannabis.

Cannabis law in Switzerland

Buying weed Switzerland

Under the Swiss Narcotics Act, cannabis is a prohibited narcotic drug. Depending on how often it is used and in what amount, cannabis can put the health of young people in particular at risk. As a psychoactive substance, cannabis is smoked, with or without tobacco, as marijuana dried flower heads or hashish resin from the flower heads. Rarely, it is consumed dissolved in drinks or food. Depending on its composition and dose, effects range from calming to euphorigenic to mildly hallucinogenic. Cannabis contains around chemical compounds. The psychoactive i. Other active substances cannabinoids like cannabidiol CBD are not subject to the Narcotics Act as they do not have comparable psychoactive effects. Top of page. From a public health perspective, frequent use of large amounts of cannabis over a long period is particularly problematic. Although this risk group in Switzerland is relatively small fewer than , people , these individuals are at increased risk of mental, social and physical problems as a result of cannabis use. The health risks of infrequent cannabis use are fairly low compared to other psychoactive substances, but by no means harmless. The risks are greater with long-term use starting at an early age. Long-term high-risk cannabis use increases the likelihood of mental issues such as depression, anxiety and personality disorders. Long-term cannabis use also harbours the risk of developing psychological dependence. The effect of THC impairs driving, the ability to pay attention, to concentrate and to learn. Continuous high levels of use can negatively impact performance at school or at work. Frequently smoking cannabis mixed with tobacco also increases the risk of respiratory or cardiovascular diseases. Moreover, since cannabis is illegal, there are no quality controls of the products. Thus, users are generally unaware of the THC content and may expose themselves to unknown risks. The Federal Office of Public Health, FOPH supports the cantons, communities and specialist institutions in developing and implementing measures for the prevention, early detection and intervention and treatment of addiction problems. The FOPH uses health promotion and prevention in the school setting to reach out to children and adolescents:. Through research projects , including monitoring and specific studies on cannabis consumption, the FOPH organizes the scientific research that is essential for planning the necessary measures. Products containing the non-intoxicating substance CBD in particular are gaining importance. Unauthorised use of cannabis or cannabis-containing products with an average of at least 1. Alongside hemp flowers and powder, cannabis products include other processed products like extracts oils and pastes , capsules sold in bulk and ready-to-use products such as food supplements, liquids for e-cigarettes, tobacco substitutes, aromatic oils, chewing gum and ointments, some of which are offered as toiletries. Recently, the production and sale of low-THC cannabis products have increased considerably and raise various health and legal issues. While these products are not subject to the Narcotics Act, they can nonetheless not be sold and advertised at will. Hemp plants contain more than 80 cannabinoids and over other active substances. CBD is not subject to the Narcotics Act, see above. The range is growing rapidly, and demand is increasing. Areas up for discussion include the possible therapeutic effects such as anti-oxidative, anti-inflammatory, anti-convulsive, anti-emetic, anxiolytic and anti-psychotic effects. However, there is currently insufficient research on the medicinal effect of CBD see also Medical use of cannabis. Swissmedic: Questions on delimitation. Since , cannabis use by adults may be punished with a fixed penalty of CHF By contrast, possession of up to 10 g of cannabis for personal use is not considered a criminal offence. However, the Juvenile Criminal Law Act applies to minors. The aim of the fixed penalty procedure was to standardise prosecution of all cannabis users in Switzerland and reduce administrative and legal costs. This aim has only partly been achieved, as there are still considerable differences between cantons regarding implementation of the fixed penalty procedure. While THC is responsible for the intoxicating effect of cannabis, CBD does not have a psychoactive effect and is therefore not covered by the Narcotics Act. Use is particularly widespread among adolescents and young adults. One in ten adolescents aged between 15 and 24 has smoked cannabis within the last month. Use decreases with age and becomes a niche phenomenon. For years, the level of cannabis use among adolescents in Switzerland has been among the highest in Europe. It is encouraging that the number of students who have consumed cannabis has declined significantly since In addition, most young people only consume it from time to time and then give it up completely after a certain period. High levels of use and long-term use are associated with a greater incidence of critical life problems, associated with serious developmental disorders, social disintegration and subsequent addiction. In general, however, adolescents who experiment with cannabis over a limited period of time and in small amounts exhibit normal, well-adjusted psychosocial development. It is therefore incorrect to refer to cannabis as a youth problem. However, it is indeed a youth phenomenon. Cannabis Examination of cannabis for extenders, blends, pesticides, microbiological and inorganic contaminations in German PDF, 2 MB, Evidence-based and impact-oriented cannabis prevention. Overall concept for protection of health for the pilot trials with cannabis Curia Vista Cannabis Policy - The questions no one asks in French. Last modification Print contact. Homepage Main navigation Content area Sitemap Search. Contact information. Cannabis as a narcotic drug As a psychoactive substance, cannabis is smoked, with or without tobacco, as marijuana dried flower heads or hashish resin from the flower heads. Health risks of cannabis use From a public health perspective, frequent use of large amounts of cannabis over a long period is particularly problematic. What is the FOPH doing to address cannabis use? Low-THC Cannabis Unauthorised use of cannabis or cannabis-containing products with an average of at least 1. Legislation Further information Research reports on Cannabis Here a list of research reports on the topic 'Cannabis' that have been funded by the Federal Office of Public Health. Addiction counseling and therapy. National Strategy on Addiction The National Strategy on Addiction aims to prevent the development of addiction, provide help to people with an addiction and reduce the negative impact on health and society.

Buying weed Switzerland